|
1
|
Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication.
|
J Virol
|
2007
|
4.64
|
|
2
|
Low sensitivity of rapid diagnostic test for influenza.
|
Clin Infect Dis
|
2009
|
3.31
|
|
3
|
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.
|
Clin Infect Dis
|
2013
|
3.00
|
|
4
|
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group.
|
J Acquir Immune Defic Syndr
|
2012
|
2.95
|
|
5
|
Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection.
|
J Acquir Immune Defic Syndr
|
2002
|
2.70
|
|
6
|
Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection.
|
JAMA
|
2007
|
2.59
|
|
7
|
Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984-2011.
|
Clin Infect Dis
|
2013
|
2.15
|
|
8
|
DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages.
|
J Immunol
|
2006
|
1.78
|
|
9
|
Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay.
|
AIDS Res Hum Retroviruses
|
2011
|
1.66
|
|
10
|
Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility.
|
J Infect Dis
|
2006
|
1.62
|
|
11
|
Multisite comparison of high-sensitivity multiplex cytokine assays.
|
Clin Vaccine Immunol
|
2011
|
1.62
|
|
12
|
Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN.
|
J Virol
|
2008
|
1.54
|
|
13
|
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.
|
J Infect Dis
|
2010
|
1.51
|
|
14
|
Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort study.
|
Atherosclerosis
|
2012
|
1.50
|
|
15
|
Rapid and sensitive detection of respiratory virus infections for directed antiviral treatment using R-Mix cultures.
|
J Clin Virol
|
2002
|
1.43
|
|
16
|
Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation.
|
AIDS
|
2011
|
1.42
|
|
17
|
Estimating the benefit of an HIV-1 vaccine that reduces viral load set point.
|
J Infect Dis
|
2007
|
1.41
|
|
18
|
B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.41
|
|
19
|
Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine.
|
J Virol
|
2002
|
1.36
|
|
20
|
Proinflammatory cytokines in HIV disease-a review and rationale for new therapeutic approaches.
|
AIDS Rev
|
2005
|
1.35
|
|
21
|
Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART.
|
PLoS One
|
2010
|
1.32
|
|
22
|
Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter -592 C/C genotype.
|
Clin Immunol
|
2003
|
1.30
|
|
23
|
DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes.
|
PLoS Pathog
|
2006
|
1.25
|
|
24
|
Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape.
|
J Virol
|
2005
|
1.25
|
|
25
|
The dual impact of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairment.
|
PLoS One
|
2011
|
1.23
|
|
26
|
Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals.
|
Clin Vaccine Immunol
|
2007
|
1.22
|
|
27
|
When to initiate highly active antiretroviral therapy: a cohort approach.
|
Am J Epidemiol
|
2003
|
1.22
|
|
28
|
Fidelity of SNP array genotyping using Epstein Barr virus-transformed B-lymphocyte cell lines: implications for genome-wide association studies.
|
PLoS One
|
2009
|
1.20
|
|
29
|
Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes.
|
Proc Natl Acad Sci U S A
|
2008
|
1.18
|
|
30
|
Clinical evaluation of multiplex real-time PCR panels for rapid detection of respiratory viral infections.
|
J Med Virol
|
2011
|
1.16
|
|
31
|
Effect of highly active antiretroviral therapy on multiple AIDS-defining illnesses among male HIV seroconverters.
|
Am J Epidemiol
|
2005
|
1.12
|
|
32
|
Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis.
|
J Clin Microbiol
|
2006
|
1.12
|
|
33
|
Comment on "characteristics of B-cell lymphomas in HIV/HCV-coinfected patients during the combined antiretroviral therapy era: an ANRS CO16 LYMPHOVIR cohort study".
|
J Acquir Immune Defic Syndr
|
2014
|
1.09
|
|
34
|
Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response.
|
J Immunol
|
2006
|
1.08
|
|
35
|
Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS.
|
PLoS Pathog
|
2007
|
1.08
|
|
36
|
Influenza and other respiratory virus infections in outpatients with medically attended acute respiratory infection during the 2011-12 influenza season.
|
Influenza Other Respir Viruses
|
2014
|
1.07
|
|
37
|
Impact of inversion of the CD4/CD8 ratio on the natural history of HIV-1 infection.
|
J Acquir Immune Defic Syndr
|
2006
|
1.06
|
|
38
|
Selective induction of CTL helper rather than killer activity by natural epitope variants promotes dendritic cell-mediated HIV-1 dissemination.
|
J Immunol
|
2013
|
1.06
|
|
39
|
The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts.
|
PLoS One
|
2013
|
1.06
|
|
40
|
Human CD8+ T cells specific for influenza A virus M1 display broad expression of maturation-associated phenotypic markers and chemokine receptors.
|
Immunology
|
2005
|
1.04
|
|
41
|
CD27 and CD57 expression reveals atypical differentiation of human immunodeficiency virus type 1-specific memory CD8+ T cells.
|
Clin Vaccine Immunol
|
2006
|
1.02
|
|
42
|
Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.01
|
|
43
|
Value of a quality assessment program in optimizing cryopreservation of peripheral blood mononuclear cells in a multicenter study.
|
Clin Vaccine Immunol
|
2013
|
1.00
|
|
44
|
Demographic and clinical factors associated with persistent symptoms after West Nile virus infection.
|
Am J Trop Med Hyg
|
2010
|
1.00
|
|
45
|
Identification of an HLA A*0201-restricted CD8(+) T-cell epitope for the glycoprotein B homolog of human herpesvirus 8.
|
Blood
|
2002
|
0.99
|
|
46
|
Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assays.
|
J Clin Microbiol
|
2002
|
0.99
|
|
47
|
Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin.
|
J Heart Lung Transplant
|
2007
|
0.98
|
|
48
|
Early HLA-B*57-restricted CD8+ T lymphocyte responses predict HIV-1 disease progression.
|
J Virol
|
2012
|
0.98
|
|
49
|
Association of polymorphisms in human leukocyte antigen class I and transporter associated with antigen processing genes with resistance to human immunodeficiency virus type 1 infection.
|
J Infect Dis
|
2003
|
0.97
|
|
50
|
Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells.
|
J Virol
|
2002
|
0.96
|
|
51
|
Primary human immunodeficiency virus type 1-specific CD8+ T-cell responses induced by myeloid dendritic cells.
|
J Virol
|
2009
|
0.95
|
|
52
|
Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
|
J Clin Virol
|
2008
|
0.95
|
|
53
|
Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8(+) T cell immunity.
|
J Leukoc Biol
|
2008
|
0.94
|
|
54
|
Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection.
|
Clin Vaccine Immunol
|
2008
|
0.94
|
|
55
|
Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons.
|
J Virol
|
2005
|
0.94
|
|
56
|
B-cell activation induced microRNA-21 is elevated in circulating B cells preceding the diagnosis of AIDS-related non-Hodgkin lymphomas.
|
AIDS
|
2012
|
0.93
|
|
57
|
MDSC: a new player in HIV immunopathogenesis.
|
AIDS
|
2012
|
0.93
|
|
58
|
A Twenty-Two-Year-Old Community Advisory Board: Health Research as an Opportunity for Social Change.
|
J Community Pract
|
2010
|
0.92
|
|
59
|
Identification of class I HLA T cell control epitopes for West Nile virus.
|
PLoS One
|
2013
|
0.91
|
|
60
|
Cytokine production by human herpesvirus 8-infected dendritic cells.
|
J Gen Virol
|
2009
|
0.89
|
|
61
|
Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection.
|
Clin Vaccine Immunol
|
2007
|
0.89
|
|
62
|
Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapy.
|
J Antimicrob Chemother
|
2013
|
0.88
|
|
63
|
Dendritic cells reveal a broad range of MHC class I epitopes for HIV-1 in persons with suppressed viral load on antiretroviral therapy.
|
PLoS One
|
2010
|
0.88
|
|
64
|
Stuck in the middle: longitudinal HIV-related health disparities among men who have sex with men and women.
|
J Acquir Immune Defic Syndr
|
2014
|
0.88
|
|
65
|
CD4⁺CD73⁺ T cells are associated with lower T-cell activation and C reactive protein levels and are depleted in HIV-1 infection regardless of viral suppression.
|
AIDS
|
2013
|
0.87
|
|
66
|
Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes.
|
J Immunol Methods
|
2006
|
0.87
|
|
67
|
Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cells.
|
Clin Vaccine Immunol
|
2009
|
0.87
|
|
68
|
Surface phenotype and functionality of WNV specific T cells differ with age and disease severity.
|
PLoS One
|
2010
|
0.87
|
|
69
|
CD4+ T-cell counts and plasma HIV-1 RNA levels beyond 5 years of highly active antiretroviral therapy.
|
J Acquir Immune Defic Syndr
|
2011
|
0.87
|
|
70
|
Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjects.
|
AIDS
|
2007
|
0.86
|
|
71
|
Treating HIV-1 infection with dendritic cells.
|
Curr Opin Mol Ther
|
2007
|
0.86
|
|
72
|
Herpesvirus infections in organ transplant recipients.
|
Clin Diagn Lab Immunol
|
2003
|
0.86
|
|
73
|
Comparative risk of liver-related mortality from chronic hepatitis B versus chronic hepatitis C virus infection.
|
Clin Infect Dis
|
2012
|
0.84
|
|
74
|
Professional antigen presenting cells in human herpesvirus 8 infection.
|
Front Immunol
|
2013
|
0.84
|
|
75
|
Priming of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cell responses by dendritic cells loaded with HIV-1 proteins.
|
J Infect Dis
|
2002
|
0.83
|
|
76
|
Predictors of the isolated hepatitis B core antibody pattern in HIV-infected and -uninfected men in the multicenter AIDS cohort study.
|
Clin Infect Dis
|
2012
|
0.83
|
|
77
|
Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods: A Cohort Study.
|
Ann Intern Med
|
2015
|
0.83
|
|
78
|
PD-1 blockade: A promising immunotherapy for HIV?
|
Cellscience
|
2009
|
0.82
|
|
79
|
Monofunctional and polyfunctional CD8+ T cell responses to human herpesvirus 8 lytic and latency proteins.
|
Clin Vaccine Immunol
|
2010
|
0.82
|
|
80
|
Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial.
|
J Acquir Immune Defic Syndr
|
2013
|
0.81
|
|
81
|
CD8+ T-cell immunity to HIV infection.
|
Clin Lab Med
|
2002
|
0.81
|
|
82
|
Preserving HIV-specific T cell responses: does timing of antiretroviral therapy help?
|
Curr Opin HIV AIDS
|
2015
|
0.80
|
|
83
|
An optimized sensitive method for quantitation of DNA/RNA viruses in heparinized and cryopreserved plasma.
|
J Virol Methods
|
2011
|
0.80
|
|
84
|
Regulatory T cells in HIV immunotherapy.
|
HIV Ther
|
2010
|
0.79
|
|
85
|
Alterations in cholesterol metabolism restrict HIV-1 trans infection in nonprogressors.
|
MBio
|
2014
|
0.79
|
|
86
|
Minimization of genetic distances by the consensus, ancestral, and center-of-tree (COT) sequences for HIV-1 variants within an infected individual and the design of reagents to test immune reactivity.
|
Virology
|
2006
|
0.78
|
|
87
|
Activation of HIV type 1 specific cytotoxic T lymphocytes from semen by HIV type 1 antigen-presenting dendritic cells and IL-12.
|
AIDS Res Hum Retroviruses
|
2006
|
0.77
|
|
88
|
Detection of HIV-1 RNA/DNA and CD4 mRNA in feces and urine from chronic HIV-1 infected subjects with and without anti-retroviral therapy.
|
AIDS Res Ther
|
2009
|
0.77
|
|
89
|
"In vitro systems to characterize the immune response to HIV-1 and HIV-1 vaccine candidates", NIAID Workshop Report, Bethesda, August 4, 2010.
|
Vaccine
|
2011
|
0.77
|
|
90
|
Fifty percent tissue culture infective dose assay for determining the titer of infectious human herpesvirus 8.
|
J Clin Microbiol
|
2013
|
0.77
|
|
91
|
Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181.
|
Clin Vaccine Immunol
|
2010
|
0.77
|
|
92
|
HIV's ticket to ride: Cytotoxic T-lymphocyte-activated dendritic cells exploited for virus intercellular transfer.
|
AIDS Res Hum Retroviruses
|
2014
|
0.76
|
|
93
|
Lack of associations between HLA class II alleles and resistance to HIV-1 infection among white, non-Hispanic homosexual men.
|
J Acquir Immune Defic Syndr
|
2004
|
0.76
|
|
94
|
Brief Report: Changes in Levels of Inflammation After Antiretroviral Treatment During Early HIV Infection in AIDS Clinical Trials Group Study A5217.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|
|
95
|
The relationship between antibody to R7V and progression of HIV type 1 infection.
|
AIDS Res Hum Retroviruses
|
2010
|
0.75
|
|
96
|
Subclinical herpesvirus shedding among HIV-1-infected men on antiretroviral therapy.
|
AIDS
|
2017
|
0.75
|
|
97
|
A novel anti-HIV immunotherapy to cure HIV.
|
AIDS
|
2017
|
0.75
|